Buying guide
Lingo vs Ultrahuman Ring (Air / Pro) in 2026
Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.
| Attribute | No image on file | No image on file |
|---|---|---|
| Manufacturer | Abbott | Ultrahuman |
| Form factor | biometric | biometric |
| Maturity | commercial | commercial |
| Availability | shipping-nowshipping | shipping-nowshipping |
| Price | $54 (actual sale price) | $349-$399 (actual sale price) |
| Capability claims | — |
|
| Brain | — | — |
| Verified deployments | 1Abbott | 1Ultrahuman |
| Privacy practices | 4third-party-sharing, data-deletion-control, biometric-storage, training-data-use | 8cloud-upload, third-party-sharing, data-retention, data-deletion-control, biometric-storage, location-tracking, data-sale, training-data-use |
| Sources on file | 8 | 12 |
Editorial summaries
Lingo
Abbott's Lingo is an over-the-counter continuous glucose monitor for non-diabetic and wellness consumers, built on Abbott's FreeStyle Libre sensor platform (FDA 510(k) K233655, decided May 29, 2024; Class II integrated CGM): a disposable biosensor worn up to 14 days on the back of the upper arm. It is the adaptive-algorithmic end of the glucose cell, the documented contrast to Stelo's generative AI: the app's 'Lingo Count' daily glucose-spike metric with adaptive targets, food and activity logging, and rule-based personalized recommendations are adaptive-algorithmic, not generative. 'Lingo Live' is free roughly 30-minute sessions with human Abbott nutritionists, not an AI coach, and DEPLOY surfaces that distinction prominently. Pricing starts at about $54 for a 2-week single-biosensor plan, with recurring biweekly and monthly multi-sensor tiers. From Abbott (NYSE: ABT). Cap-flag: the cleared indication is adults 18+ not on insulin, explicitly NOT for diagnosis of any disease including diabetes.
Ultrahuman Ring (Air / Pro)
The Ultrahuman Ring (the Ring Air, plus the Ring Pro that brought a global roughly $349-to-$399 launch around February 2026 with 15-day battery; from Ultrahuman, founded 2019 in Bengaluru by CEO Mohit Kumar and co-founder Vatsal Singhal, with a Plano, Texas factory) is the market-access-redesigned archetype of the ring sub-cohort. Its AI comes via modular 'PowerPlugs' (metabolic and cardio adaptability, circadian rhythm, caffeine window, AFib, cycle), with no mandatory subscription for core tracking and some premium PowerPlugs paid (AFib at about $4.90/month); AFib detection runs through the third-party FibriCheck app, not a native FDA clearance. The within-entity verified-vs-claimed exemplar is market access, not the product: US market access was blocked on October 21, 2025 under Oura's ITC patent ruling (US Patent 11,868,178), then restored on March 24, 2026 when the Ring Pro's unibody redesign cleared US Customs, a company-availability story that parallels the Apple Watch's disabled-then-restored blood-oxygen feature. The product and AI existed globally throughout; only US market access was interrupted. Price is about $349 (Air) to $399 (Pro), subscription-augmented.
Machine-readable: this page as markdown.